ZIVO (OTC)
ZIVO BIOSCIENCE INC
$4.291100
+0.000000 (+0.00%)
Prev close: $4.291100
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- John Bernard Payne
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $44.85M
- Employees
- 8
- P/E (TTM)
- -3.64
- P/B (TTM)
- -10.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2025 (Q2)
|
$-0.43 | $-0.42 | -0.0118 | -2.82% |
|
Mar 2025 (Q1)
|
$-1.12 | $-0.53 | -0.5896 | -111.16% |
|
Dec 2024 (Q4)
|
$-0.36 | $-0.57 | +0.2112 | +36.97% |
|
Sep 2024 (Q3)
|
$-0.67 | $-0.40 | -0.2722 | -68.43% |
Financial Statements
| Revenues | $209.03K |
| Benefits Costs and Expenses | $13.54M |
| Cost Of Revenue | $142.82K |
| Costs And Expenses | $8.69M |
| Gross Profit | $66.21K |
| Operating Expenses | $8.52M |
| Research and Development | $3.70M |
| Other Operating Expenses | $4.83M |
| Operating Income/Loss | -$8.46M |
| Income/Loss From Continuing Operations After Tax | -$8.49M |
| Income/Loss From Continuing Operations Before Tax | -$13.33M |
| Net Income/Loss | -$8.49M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.49M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.49M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Diluted Earnings Per Share | -$2.18 |
| Diluted Average Shares | 3,918,371 |
| Assets | $559.45K |
| Current Assets | $281.40K |
| Noncurrent Assets | $278.05K |
| Liabilities | $3.85M |
| Current Liabilities | $3.61M |
| Accounts Payable | $992.99K |
| Other Current Liabilities | $2.62M |
| Noncurrent Liabilities | $231.79K |
| Equity | -$3.29M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$3.29M |
| Liabilities And Equity | $559.45K |
| Net Cash Flow From Operating Activities | -$3.08M |
| Net Cash Flow From Operating Activities, Continuing | -$3.08M |
| Net Cash Flow From Investing Activities | $102.18K |
| Net Cash Flow From Investing Activities, Continuing | $102.18K |
| Net Cash Flow From Financing Activities | $2.98M |
| Net Cash Flow From Financing Activities, Continuing | $2.98M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$8.49M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.49M |
| Other Comprehensive Income/Loss | $0.00 |